
Ep147: Reid Huber on Investing in the Future of Medicine
The Long Run with Luke Timmerman
Navigating the Current State of the Stock Market and Legislation Impact
Delving into the disconnect between stock market trends and scientific innovation, this chapter explores the effects of the Inflation Reduction Act on drug pricing and investment decisions within the pharmaceutical industry. The speaker reflects on the potential consequences of legislation on new medicine development while expressing optimism for the ongoing golden age of drug discovery.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.